These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9543728)

  • 1. Synthesis and in vitro and in vivo evaluation of dopaminergic ergoline derivatives.
    Mantegani S; Brambilla E; Caccia C; Di Salle E; Cervini MA; McArthur RA; Traquandi G; Varasi M
    Farmaco; 1998 Jan; 53(1):65-72. PubMed ID: 9543728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antihypertensive activity of 2,4-dioxoimidazolidin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives.
    Mantegani S; Brambilla E; Caccia C; Chiodini L; Ruggieri D; Lamberti E; Di Salle E; Salvati P
    Farmaco; 1998 Apr; 53(4):293-304. PubMed ID: 9658588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and dopamine antagonist activity of 2-thioether derivatives of the ergoline ring system.
    Tupper DE; Pullar IA; Clemens JA; Fairhurst J; Risius FC; Timms GH; Wedley S
    J Med Chem; 1993 Apr; 36(7):912-8. PubMed ID: 8096548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of new (5R,8R,10R)-ergoline derivatives with antihypertensive or dopaminergic activity.
    Ohno S; Adachi Y; Koumori M; Mizukoshi K; Nagasaka M; Ichihara K; Kato E
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1463-73. PubMed ID: 7923470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive ergoline derivatives.
    Mantegani S; Temperilli A; Traquandi G; Salvati P; Di Salle E; Lamberti E; Bonsignori A
    Drug Des Deliv; 1987 May; 1(4):313-23. PubMed ID: 3509340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by partial ergoline.
    Rabey JM; Passeltiner P; Markey K; Asano T; Goldstein M
    Brain Res; 1981 Nov; 225(2):347-56. PubMed ID: 6118195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive ergolinepropionamides.
    Bernardi L; Bosisio G; Mantegani S; Sapini O; Temperilli A; Salvati P; di Salle E; Arcari G; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1094-8. PubMed ID: 6685485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of D-oxa tricyclic partial ergolines as dopamine agonists.
    Booher RN; Kornfeld EC; Smalstig EB; Clemens JA
    J Med Chem; 1987 Mar; 30(3):580-3. PubMed ID: 3102743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New dopaminergic and potential anti-parkinson compounds, N,N-disubstituted beta-(3,4-dihydroxyphenyl)ethylamines.
    Ginos JZ; Cotzias GC; Doroski D
    J Med Chem; 1978 Feb; 21(2):160-5. PubMed ID: 563919
    [No Abstract]   [Full Text] [Related]  

  • 10. Ergoline congeners as potential inhibitors of prolactin release. 2.
    Rusterholz DB; Barfknecht CF; Clemens JA
    J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity.
    McQuaid LA; Latz JE; Clemens JA; Fuller RW; Wong DT; Mason NR
    J Med Chem; 1989 Oct; 32(10):2388-96. PubMed ID: 2571732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergoline congeners as potential inhibitors of prolactin release. 3. Derivatives of 3-phenylpiperidine.
    Rusterholz DB; Barfknecht CF; Clemens JA
    J Med Chem; 1977 Jan; 20(1):85-8. PubMed ID: 13217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bi- and tricyclic ergoline analogs with dopaminergic actions].
    Gmeiner P
    Pharm Unserer Zeit; 1994 Jun; 23(3):169-73. PubMed ID: 7913751
    [No Abstract]   [Full Text] [Related]  

  • 14. Ergot alkaloids. Synthesis of 6-methyl-8-ergolenes as inhibitors of prolactin release.
    Li GS; Robinson JM; Floss HG; Cassady JM
    J Med Chem; 1975 Sep; 18(9):892-5. PubMed ID: 1159711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiulcer and antisecretory ergoline derivatives.
    Ruggieri D; Arrigoni C; Di Salle E; Temperilli A; Giudici D
    Farmaco; 1989 Jan; 44(1):39-50. PubMed ID: 2742720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troponoids. 7. Chemistry and dopamine agonist activity of ciladopa and related aralkyltroponylpiperazines.
    Bagli J; Bogri T; Voith K; Lee D
    J Med Chem; 1986 Feb; 29(2):186-93. PubMed ID: 3950903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists.
    Bach NJ; Kornfeld EC; Jones ND; Chaney MO; Dorman DE; Paschal JW; Clemens JA; Smalstig EB
    J Med Chem; 1980 May; 23(5):481-91. PubMed ID: 7189782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
    Flückiger E; Briner U; Clark B; Closse A; Enz A; Gull P; Hofmann A; Markstein R; Tolcsvai L; Wagner HR
    Experientia; 1988 May; 44(5):431-6. PubMed ID: 3371446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nidation inhibition by simple ergoline derivatives.
    Rezábek K; Cassady JM; Floss HG
    J Pharm Sci; 1975 Jun; 64(6):1045-6. PubMed ID: 1133727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amesergide and structurally related nor-D-ergolines: 5HT2 receptor interactions in the rat.
    Martinelli MJ; Bloomquist W; Peterson BC; Cohen ML
    J Med Chem; 1993 Sep; 36(18):2671-5. PubMed ID: 8410979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.